Vnitr Lek 2023, 69(8):E19-E25 | DOI: 10.36290/vnl.2023.108

Overlooked upper gastrointestinal tract carcinoma (PEUGIC) - from epidemiology to root cause analysis

Michal Štěpán1, 3, Barbora Pipek1, 2, 3, 4, Patrik Tokoš1, Petr Fojtík1, 4, Přemysl Falt2, 3
1 Centrum péče o zažívací trakt, Nemocnice Agel Ostrava-Vítkovice
2 II. interní klinika-gastroenterologická a geriatrická FN Olomouc
3 Lékařská fakulta, Univerzita Palackého v Olomouci
4 Lékařská fakulta, Ostravská univerzita

PEUGIC (Post Esophagogastroduodenoscopy Upper Gastrointestinal Cancer) is cancer in the upper gastrointestinal tract, which at the time of diagnosis was preceded by gastroscopy in the last 3 years, which did not show this cancer. Its incidence is directly related to the quality of performing upper endoscopy and is therefore a parameter that can be monitored to assess the quality of upper endoscopy at individual endoscopy units. According to available data, PEUGIC accounts for approximately 10 % of all diagnosed cancers of the upper GIT (gastrointestinal tract). It occurs more often in women, at a younger age than common cancers and in patients with higher comorbidities. The most common causes include insufficient quality of endoscopy, insufficient assessment of precancerous conditions and focal lesions during endoscopy and inadequate decisions about further surveillance. In this article, we address the epidemiology of PEUGIC, review the literature, and analyze the main causes leading to it.

Keywords: upper endoscopy, PEUGIC, endoscopy quality.

Accepted: December 5, 2023; Published: December 18, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štěpán M, Pipek B, Tokoš P, Fojtík P, Falt P. Overlooked upper gastrointestinal tract carcinoma (PEUGIC) - from epidemiology to root cause analysis. Vnitr Lek. 2023;69(8):E19-25. doi: 10.36290/vnl.2023.108.
Download citation

References

  1. Alexandre L, Tsilegeridis-Legeris T, Lam S. Clinical and Endoscopic Characteristics Associated With Post-Endoscopy Upper Gastrointestinal Cancers: A Systematic Review and Meta-analysis. Gastroenterology. 2022;162(4):1123-1135. Available from DOI: https://doi.org/10.1053/j.gastro.2021.12.270. Go to original source... Go to PubMed...
  2. Chen D, Fu M, Chi L. Prognostic and predictive value of a pathomics signature in gastric cancer. Nat Commun. 2022;13(1):6903. Available from DOI: https://doi.org/10.1038/s41467-022-34703-w. Go to original source... Go to PubMed...
  3. Liu ChQ, Ma YL, Qin Q. Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040. Thorac Cancer. 2023;14(1):3-11. Available from DOI: https://doi.org/10.1111%2F1759-7714.14745. Go to original source... Go to PubMed...
  4. Novotvary 2018 ČR. Data z 2018. Ústav zdravotnických informací a statistiky ČR. [cit.2021-04-25]. Available from www: https://www.uzis.cz/res/f/008352/novotvary2018.pdf.
  5. Martinek J, Trunecka P, et al. Gastroenterologie a hepatologie v algoritmech. Maxdorf: Praha 2021: 143-154. ISBN 978-80-7345-684-9.
  6. Holmberg D, Santoni G, Euler-Chelpin MC, et al. Incidence and Mortality in Upper Gastrointestinal Cancer After Negative Endoscopy for Gastroesophageal Reflux Disease. Gastroenterology 2022;162(2):431-438. Available from DOI: https://doi.org/10.1053/j.gastro.2021.10.003. Go to original source... Go to PubMed...
  7. Goetz N, Lamba M, Ryan K, et al. Post-Endoscopy Upper Gastrointestinal Cancer Rate in a Tertiary Referral Centre: An Australian Data Linkage Analysis. J Gastrointest Cancer 2022; online ahead of print. Available from https://doi.org/10.1007/s12029-022-00874-4. Go to original source... Go to PubMed...
  8. Menon S, Trudgill N. How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis. Endosc Int Open 2014; 2(2): e46-e50. Available from DOI: https://doi.org/10.1055%2Fs-0034-1365524. Go to original source... Go to PubMed...
  9. Chadwick G, Groene O, Hoare J, et al. A population-based, retrospective, cohort study of esophageal cancer missed at endoscopy. Endoscopy. 2014;46 (7):553-560. Available from DOI: https://doi.org/10.1055/s-0034-1365646. Go to original source... Go to PubMed...
  10. Chadwick G, Groene O, Riley S, et al. Gastric cancers missed during endoscopy in England. Clin Gastroenterol Hepatol. 2015;13(7):1264-1270. Available from DOI: https://doi.org/10.1016/j.cgh.2015.01.025. Go to original source... Go to PubMed...
  11. Pimenta-Melo AR, Monteiro-Soares M, Libânio D, et al. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28(9):1041-1049. Available from DOI: https://doi.org/10.1097/meg.0000000000000657. Go to original source... Go to PubMed...
  12. Cheung D, Menon S, Hoare J, et al. Factors associated with upper gastrointestinal cancer occurrence after endoscopy that did not diagnose cancer. Dig Dis Sci. 2016;61(9):2674-2684. Available from DOI: https://doi.org/10.1007/s10620-016-4176-4. Go to original source... Go to PubMed...
  13. Kamran U, King D, Abbasi A, et al. A root cause analysis system to establish the most plausible explanation for post-endoscopy upper gastrointestinal cancer. Endoscopy. 2023; 55(2):109-118. Available from DOI: https://doi.org/10.1055/a-1917-0192. Go to original source... Go to PubMed...
  14. Januszewicz W, Witczak K, Wieszczy P, et al. Prevalence and risk factors of upper gastrointestinal cancers missed during endoscopy: a nationwide registry-based study. Endoscopy. 2022;54(7):653-660. Available from DOI: https://doi.org/10.1055/a-1675-4136. Go to original source... Go to PubMed...
  15. Beg S, Ragunat K, Wyman A, Banks M, Trudgill N, Pritchard D, et al. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut. 2017;66(11):1886-1899. Available from DOI: https://doi.org/10.1136/gutjnl-2017-314109. Go to original source... Go to PubMed...
  16. Bisschops R, Areia M, Coron E, Dobru D, Kaskas B, Kuvaev R, et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2016;48(9):843-864. Available from DOI: http://dx.doi.org/10.1055/s-0042-113128. Go to original source... Go to PubMed...
  17. Januszewicz W, Kaminski MF. Quality indicators in diagnostic upper gastrointestinal endoscopy. Therapeutic Advances in Gastroenterology. 2020;13:1-19. Available from DOI: https://doi.org/10.1177%2F1756284820916693. Go to original source... Go to PubMed...
  18. Cyrany J, Balihar K, Falt P, et al. Gastroskopie - standardy kvality České gastroenterologické společnosti ČLS JEP. Gastroent Hepatol. 2022;76(3):194-211. Dostupné z DOI: https://doi.org/10.48095/ccgh2022194. Go to original source...
  19. Fujita S. Biology of early gastric carcinoma. Pathol Res Pract. 1978;163 (4):297-309. Available from DOI: https://doi.org/10.1016/s0344-0338(78)80028-4. Go to original source... Go to PubMed...
  20. Yalamarthi S, Witherspoon P, McCole D, et al. Missed diagnoses in patients with upper gastrointestinal cancers. Endoscopy. 2004;36(10):874-879. Available from DOI: https://doi.org/10.1055/s-2004-825853. Go to original source... Go to PubMed...
  21. Stepan M, Falt P, Pipek B, et al. Administration of mucolytic solution before upper endoscopy - double-blind, monocentric, randomized study. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic. 2023;167(1):69-73. Available from DOI: https://doi.org/10.5507/bp.2021.038. Go to original source... Go to PubMed...
  22. Elvas L, Areia M, Brito D, Alves S, Saraiva S, Cadime AT. Premedication with simethicone and N-acetylcysteine in improving visibility during upper endoscopy: a double-blind randomized trial. Endoscopy. 2017;49(2):139-145. Available from DOI: http://dx.doi.org/10.1055/s-0042-119034. Go to original source... Go to PubMed...
  23. Stepan M, Fojtik P, Falt P, et al. Administration of maximum dose of mucolytic solution before upper endoscopy-a double-blind, randomized trial. Eur J Gastroenterol Hepatol. 2023;35(6):635-640. Available from DOI: https://doi.org/10.1097/meg.0000000000002559. Go to original source... Go to PubMed...
  24. Manfredi G, Berte R, Liritano E, et al. Premedication with simethicone and N-acetylcysteine for improving mucosal visibility during upper gastrointestinal endoscopy in a Western population. Endosc Int Open. 2021; 09(02): E190-E194. Available from DOI: https://doi.org/10.1055/a-1315-0114. Go to original source... Go to PubMed...
  25. Wang YR, Loftus EV, Judge TA, et al. Rate and predictors of interval esophageal and gastric cancers after esophagogastroduodenoscopy in the United States. Digestion. 2016; 94(3):176-180. Available from DOI: https://doi.org/10.1159/000452794. Go to original source... Go to PubMed...
  26. Hernanz N, Rodriguez de Santiago E, Marcos Prieto HM et al. Characteristics and consequences of missed gastric cancer: a multicentric cohort study. Dig Liver Dis. 2019; 51(6): 894-900. Dostupné z DOI: https://doi.org/10.1016/j.dld.2019.02.006. Go to original source... Go to PubMed...
  27. Rodriguez de Santiago E, Hernanz N, Marcos-Prieto HM, et al. Rate of missed oesophageal cancer at routine endoscopy and survival outcomes: A multicentric cohort study. United European Gastroenterol J. 2019;7(2):189-198. Available from DOI: https://doi.org/10.1177/2050640618811477. Go to original source... Go to PubMed...
  28. Rutter MD, Beintaris I, Valori R, et al. World Endoscopy Organization consensus statements on post-colonoscopy and post-imaging colorectal cancer. Gastroenterology 2018;155(3):909-925. Available from DOI: https://doi.org/10.1053/j.gastro.2018.05.038. Go to original source... Go to PubMed...
  29. Jin S, Jeon SW, Kwon Y, et al. Optimal endoscopic screening interval for early detection of gastric cancer: a single-center study. J Korean Med Sci. 2018;33(23):e166. Available from DOI: https://doi.org/10.3346%2Fjkms.2018.33.e166. Go to original source... Go to PubMed...
  30. Cho YS, Chung IK, Kim JH, et al. Risk factors of developing interval early gastric cancer after negative endoscopy. Dig Dis Sci. 2015;60(4):936-43. Available from DOI: https://doi.org/10.1007/s10620-014-3384-z. Go to original source... Go to PubMed...
  31. Beck M, Bringeland EA, Qvigstad G, et al. Gastric Cancers Missed at Upper Endoscopy in Central Norway 2007 to 2016-A Population-Based Study. Cancers. 2021,13(22): 5628. Available from DOI: https://doi.org/10.3390/cancers13225628. Go to original source... Go to PubMed...
  32. PGD Guillena, VJM Alvarado, MJ Ramiro, et al. Gastric cancer missed at esophagogastroduodenoscopy in a well-defined Spanish population. Dig Liver Dis. 2019;51(8):1123-1129. Available from DOI: https://doi.org/10.1016/j.dld.2019.03.005. Go to original source... Go to PubMed...
  33. Gavric A, Hanzel J, Zagar T, et al. Survival outcomes and rate of missed upper gastrointestinal cancers at routine endoscopy: a single centre retrospective cohort study. Eur J Gastroenterol Hepatol. 2020;32(10):1312-1321. Available from DOI: https://doi.org/10.1097/MEG.0000000000001863. Go to original source... Go to PubMed...
  34. Januszewicz W, Wieszczy P, Bialek A, et al. Endoscopist biopsy rate as a quality indicator for outpatient gastroscopy: a multicenter cohort study with validation. Gastrointest Endosc. 2019;89(6):1141-1149. Available from DOI: https://doi.org/10.1016/j.gie.2019.01.008. Go to original source... Go to PubMed...
  35. Tai F.W.D, Wray N, Sidhu R, et al. Factors associated with oesophagogastric cancers missed by gastroscopy: a case-control study. Frontline Gastroenterol. 2019;11:194-201. Available from DOI: http://dx.doi.org/10.1136/flgastro-2019-101217. Go to original source... Go to PubMed...
  36. van Putten M, Johnston BT, Murray LJ, et al. Missed' oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus patients: a large population-based study. United European Gastroenterol J. 2018;6 (4):519-528. Available from DOI: https://doi.org/10.1177/2050640617737466. Go to original source... Go to PubMed...
  37. Bloomfeld R.S, Bridgers 3rd, D.I, Pineau B.C. Sensitivity of upper endoscopy in diagnosing esophageal cancer. Dysphagia. 2005;20:278-282. Available from DOI: https://doi.org/10.1007/s00455-005-0025-x. Go to original source... Go to PubMed...
  38. Dhaliwal L, Codipilly DC, Gandhi P, et al. Neoplasia detection rate in Barrett's esophagus and its impact on missed dysplasia: results from a large population-based database. Clin Gastroenterol Hepatol. 2021;19:922-929.e1. Available from DOI: https://doi.org/10.1016/j.cgh.2020.07.034. Go to original source... Go to PubMed...
  39. Vajravelu RK, Kolb JM, Thanawala SU, et al. Characterization of prevalent, post-endoscopy, and incident esophageal cancer in the United States: a large retrospective cohort study. Clin Gastroenterol Hepatol. 2022;20 (8):1739-1747. Available from DOI: https://doi.org/10.1016/j.cgh.2021.02.005. Go to original source... Go to PubMed...
  40. Hamashima C, Shabana M, Okamoto M, et al. Survival analysis of patients with interval cancer undergoing gastric cancer screening by endoscopy. PLoS One. 2015; 10e0126796. Available from DOI: https://doi.org/10.1371/journal.pone.0126796. Go to original source... Go to PubMed...
  41. Hosokawa O, Hattori M, Douden K, et al. Difference in accuracy between gastroscopy and colonoscopy for detection of cancer. Hepatogastroenterology. 2007;54(74):442-444. Available from https://pubmed.ncbi.nlm.nih.gov/17523293/.
  42. Iida T, Yamashita K, Ohwada S, et al. Natural history of gastric cancer from a retrospective review of endoscopic images of older patients with interval gastric cancer. Geriatr Gerontol Int. 2018;18(7):997-1002. Dostupné z DOI: https://doi.org/10.1111/ggi.13289. Go to original source... Go to PubMed...
  43. Leung WK, Ho HJ, Lin JT, et al. Prior gastroscopy and mortality in patients with gastric cancer: a matched retrospective cohort study. Gastrointest Endosc. 2018; 87(1):119-127.e3. Available from DOI: https://doi.org/10.1016/j.gie.2017.06.013. Go to original source... Go to PubMed...
  44. Raftopoulos S.C, Segarajasingam D.S, Burke V, et al. A cohort study of missed and new cancers after esophagogastroduodenoscopy. Am J Gastroenterol. 2010;105(6):1292-1297. Available from https://journals.lww.com/ajg/abstract/2010/06000/a_cohort_study_of_missed_and_new_cancers_after.15.aspx. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.